Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Magle Chemoswed Holding

8.05 SEK

Less than 1K followers

MAGLE

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Magle Chemoswed Holding

Q1/24Q2/24Q3/24Q4/242024Q1/25Q2/25Q3/25
Revenue38.246.064.687.2236.081.452.471.5
EBITDA7.05.3-55.2101.758.918.8-20.633.4
EBIT4.21.3-67.985.623.22.1-29.020.3
EBIT-%10.9 %2.9 %-105.0 %98.1 %9.8 %2.6 %-55.4 %28.3 %
Profit before taxes3.5-0.010.7-2.012.2-1.1-27.92.9
Net income2.90.29.6-0.711.9-1.2-27.83.1
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.